A recent study has been dedicated to verifying, through a meta-analysis, how cell therapy works when used to treat COVID-19.
The use of cell therapy to treat patients with COVID-19 could reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis carried out by researchers at the University of São Paulo (USP), in Brazil. in collaboration with colleagues from Germany and the United States … + read more
Long-term remission with CAR-T cell immunotherapy in refractory lupus
The treatment maintains its effect even after the reappearance of the initially eliminated B lymphocytes. + read more
Innovation continues in cell therapy for cardiac regeneration
The generation in a single step of cells specialized in the electrical conduction of the heart opens new avenues of treatment for heart disease. + read more
-
Conjugation with cytokines increases the effectiveness and safety of cell therapy in cancer
The process can be implemented in a simple way and limits the activity of cytokines to the tumor environment. + read more
-
Success of cell therapy in chronic heart failure
The treatment improves ejection fraction and reduces the risk of cardiovascular accidents. + read more
Umbilical cord banks, new cell therapy centers
Cellular therapy based on cord cells fills important gaps in the treatment of various diseases, hence the importance of having more efficient and modern cord banks. + read more
The CSIC studies the implication of cellular aging in the effects of Covid-19
The implication of cellular aging in the effects of Covid-19 has been proven. + read more
--